Ovarian cancer patients have been found to have a higher concentration of inflammatory cytokines such as IL-6, CCL2/MCP-1, and TNF-α, which play an important role in the disease’s genesis and progression. This evidence concerns the gene CCL2 and ovarian carcinoma.